Close Menu

White House

The funding will leverage genomics, informatics, and health information technologies to accelerate biomedical discoveries and yield more personalized medical treatments for patients in the US.

NEW YORK (GenomeWeb News) – The Obama Administration tomorrow will honor several genomics and molecular biology researchers who have focused on making large and complex sets of biological data open and widely accessible to the larger research community.

NEW YORK (GenomeWeb News) – The long-looming approach of the end-of-year deadline to avert a federal 'fiscal cliff' - the combined expiration of major tax cuts and enactment of across-the-board cuts to federal discretionary spending - has spurred the US research community into action as they have

In a new report, the White House highlights four major technology development goals of the Recovery Act, including slashing the cost of genome sequencing.

President Obama's bioethics commission will produce a report on what role the government should take in spurring science and maintaining safety in synthetic biology.

President Obama has tasked his bioethics commission with reviewing the implications of JCVI's breakthrough in synthetic biology.

Around the Regions: May 1, 2009

Premium

California Institute for Regenerative Medicine, Vermont Pharma Marketing Disclosure Bills, New England Biotech Association, US Energy Frontier Research Centers, Donald Danforth Plant Science Center, New York Biotechnology Association, Pharmaceutical Research and Manufacturers of America, Idea Networks of Biomedical Research Excellence, Pittsburgh Entrepreneur Fund, Massachusetts Life Sciences Center Accelerator Program, Maryland Technology Development Corporation, San Diego Center for Algae Biotechnology

Obama said that the US is in danger of slipping from its lead spot in science innovation and called for "a historic investment" in research and education that would fuel innovation as the GI Bill did a half-century ago.

Industry stakeholders and patient advocates are urging the government to ensure that any resulting comparative effectiveness program not focus solely on reducing cost but on using pharmacogenomics to improve patient outcomes.

Pages

Rady Children's Institute for Genomic Medicine and Deloitte are looking into the use of drones to transport samples for testing. 

Direct-to-consumer genetic testing firm 23andMe is laying off about 100 people.

Researchers from Northwestern University examined dust for antibiotic-resistance genes, New Scientist reports. 

In Science this week: researchers present a computational method for predicting cellular differentiation state from single-cell RNA sequencing data, and more.